Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Dr. Richard K. Bernstein – a pioneering figure in diabetes care and example for countless individuals living with type 1 ...

The Asus VivoWatch 6 Aero should let you stick your finger on the watch face to get a blood oxygen and blood pressure reading ...

The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...

Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are ...

The screening drive, titled ‘Mission Madhumeha’ (diabetes), was conducted from October 2024 to March 31, 2025, to assess the ...

Handok will hold a 5+1 event until the 20th at its own mall, Daily Health, and Naver Handok Mall to commemorate the official ...

Advocates say a remote care program launched by Ochsner Health helps primary care physicians better manage patients with ...

Secondly, stress and lack of sleep can significantly affect insulin sensitivity, making it harder for the body to regulate ...